immune system
• in the liver
• but no decrease is seen in the thymus or spleen
|
• the increase in serum levels of IFN gamma in null mice in response to alpha-galactosylceramide injection was only 20% of that seen in wild-type mice
|
• the increase in serum levels of interleukin 4 in null mice in response to alpha-galactosylceramide injection was only 60% of that seen in wild-type mice.
|
• liver leukocytes when stimulated with alpha-galactosylceramide for 72 hours produce less IFN gamma
• normal secretion when co-cultured with wild-type APC
• decreased production by CD4 T-cells after exposure to heat killed Propionibacterium acnes
|
• liver leukocytes when stimulated with alpha-galactosylceramide for 72 hours produce less IL-4
• normal secretion when co-cultured with wild-type antigen-presenting cells
|
• expression data indicates absence of liver damage in response to LPS administration in Propionibacterium acnes primed
|
homeostasis/metabolism
• the increase in serum levels of IFN gamma in null mice in response to alpha-galactosylceramide injection was only 20% of that seen in wild-type mice
|
• the increase in serum levels of interleukin 4 in null mice in response to alpha-galactosylceramide injection was only 60% of that seen in wild-type mice.
|
• decreased inhibition of B16 melanoma cell growth by alpha-galactosylceramide treatment
|
neoplasm
• decreased inhibition of B16 melanoma cell growth by alpha-galactosylceramide treatment
|
hematopoietic system
• in the liver
• but no decrease is seen in the thymus or spleen
|